| Literature DB >> 16790040 |
M Barat-Houari1, F Hilliou, F-X Jousset, L Sofer, E Deleury, J Rocher, M Ravallec, L Galibert, P Delobel, R Feyereisen, P Fournier, A-N Volkoff.
Abstract
BACKGROUND: Genomic approaches provide unique opportunities to study interactions of insects with their pathogens. We developed a cDNA microarray to analyze the gene transcription profile of the lepidopteran pest Spodoptera frugiperda in response to injection of the polydnavirus HdIV associated with the ichneumonid wasp Hyposoter didymator. Polydnaviruses are associated with parasitic ichneumonoid wasps and are required for their development within the lepidopteran host, in which they act as potent immunosuppressive pathogens. In this study, we analyzed transcriptional variations in the two main effectors of the insect immune response, the hemocytes and the fat body, after injection of filter-purified HdIV.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16790040 PMCID: PMC1559612 DOI: 10.1186/1471-2164-7-160
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Encapsulation of beads in Spodoptera frugiperda last instar larvae. A. Time course of encapsulation, by transmission electronic and photonic observations. a) Bead 30 minutes post-injection (p.i.). Beads are covered by an uncharacterized granular material (as described in Galleria mellonella by Schmit and Ratcliffe [115]). b) Bead 1 hour p.i. c) Bead 2 hours p.i. d) Bead 4 hours p.i. d') Detail showing desmosomes between two cells involved in the capsule. e) Bead 24 hours p.i. (phase contrast observation). B. Effect of injection of HdIV on cellular response. In a) and b) HdIV have been injected 5 hours prior to the beads, in c) HdIV and beads were injected simultaneously. a) Bead 15 hours p.i. b) Bead 6 hours p.i. c) Beads 24 hours p.i. (phase contrast observation). LB: latex bead; C: capsule; gm: granular material; des: desmosome-like junction; H: hemocyte; J: cellular junction; p: pseudopode-like extension; SB: sephadex bead; arrowheads indicate cells already partially attached to each other. The scale bar corresponds to 1 μm in all views, with exception of Figure 1d'), where the scale bar corresponds to 0.5 μm.
Figure 2Infection of Spodoptera frugiperda hemocytes after infection of untreated HdIV (left panels, a and b) and heat-inactivated HdIV (right panels, c and d) by transmission electronic observations. For both control and heat treatment, HdIV particles can be observed within the cytoplasm of hemocytes (black arrows, a and c) and in vacuoles (white arrows, b and d). C: cytoplasm; N: nucleus; V: vacuole.
List of Spodoptera frugiperda genes transcriptionally modified by HdIV infection.
| Number of clones | |||||||||
| H | F | M | L | F gene-cond° | p-value | ||||
| Sf1H03393-5-1 | Fumarate hydratase | AVI tricarboxylic acid cycle | 1 | 3 | 0 | 0 | 74 | <0.00001 | |
| Sf1H00151-5-1 | retinol dehydratase; iso-1 | AVI catalytic | 7 | 0 | 0 | 0 | 152 | <0.00001 | |
| Sf9L04641 | 90-kDa heat shock protein HSP83 | AVII stress. hsp | 0 | 0 | 2 | 5 | 33 | <0.0001 | |
| Sf1H03026-5-1 | heat shock cognate 70 protein | AVII stress. hsp | 1 | 0 | 0 | 0 | 62 | <0.00001 | |
| Sf1H00903-5-1 | prefoldin subunit 2 | AVIII processing | 2 | 0 | 1 | 0 | 91 | <0.00001 | |
| Sf1H00522-5-1 | Galectin; iso-1 | BIII lectin | 3 | 0 | 0 | 0 | 161 | <0.00001 | |
| Sf1H01648-5-1 | Galectin; iso-2 | BIII lectin | 2 | 0 | 0 | 0 | 110 | <0.00001 | |
| Sf1H01841-5-1 | lectin (CrV) | BIII lectin | 11 | 0 | 0 | 0 | 44 | <0.00001 | |
| Sf1H03263-5-1 | MBF2 | C regulator | 10 | 3 | 0 | 0 | NS | <0.00001 | |
| Sf1H00908-5-1 | PPO-1 (X 4 spots) | DI PPO | 75 | 0 | 0 | 0 | [27–144] | <0.00001 | |
| Sf1H00508-5-1 | PPO-2 (X 3 spots) | DI PPO | 60 | 0 | 0 | 0 | [67–104] | <0.00001 | |
| Sf1H01637-5-1 | Hypothetical protein A.gambiae | EII | 1 | 0 | 0 | 0 | 250 | <0.00001 | |
| Sf9L08591 | Hypothetical protein Drosophila | EII | 0 | 0 | 1 | 1 | 96 | <0.00001 | |
| Sf1H00837-3-1 | No Similarity | EIII | 1 | 0 | 0 | 0 | 134 | <0.00001 | |
| Sf1H00871-5-1 | No Similarity | EIII | 1 | 0 | 0 | 0 | 261 | <0.00001 | |
| Sf1H01434-3-1 | No Similarity | EIII | 1 | 0 | 0 | 0 | 102 | <0.00001 | |
| Sf1H02673-5-1 | No Similarity | EIII | 1 | 0 | 0 | 0 | 173 | <0.00001 | |
| Sf1H00201-3-1 | NS. similar to Hypothetical protein (5' seq) | EIII | 2 | 0 | 0 | 0 | 93 | <0.00001 | |
| Sf1H02439-5-1 | Annexin IX-B | AI Ca binding | 7 | 3 | 0 | 0 | 66 | <0.00001 | |
| Sf9L07393 | Calmodulin | AI Ca binding | 5 | 2 | 11 | 6 | 31 | <0.0001 | |
| Sf9L07135 | Cytochrome C oxydase I | AI electron transport | 162 | 117 | 232 | 146 | 30 | <0.0001 | |
| Sf1H02665-5-1 | splicing factor 3a | AII splicing | 1 | 0 | 0 | 0 | 196 | <0.00001 | |
| Sf9L06869 | cofilin | AIV actin | 16 | 1 | 10 | 2 | 62 | <0.00001 | |
| Sf1H03446-5-1 | profiling | AIV actin | 30 | 2 | 16 | 0 | 142 | <0.00001 | |
| Sf9L03392 | Thymosin beta | AIV actin | 7 | 1 | 3 | 13 | 33 | <0.0001 | |
| Sf9L06055 | alpha tubulin | AIV tubulin | 5 | 5 | 7 | 7 | 56 | <0.00001 | |
| Sf9L01568 | beta-1 tubulin | AIV tubulin | 1 | 2 | 2 | 1 | NS | <0.00001 | |
| Sf1H02495-5-1 | synaptotagmin-like; granuphilin | AIX exocytosis | 2 | 0 | 0 | 0 | 27 | <0.0001 | |
| Sf9L01210 | Ribosomal protein S24 | AV ribosomal | 1 | 0 | 4 | 21 | 84 | <0.00001 | |
| Sf1H02303-5-1 | kynurenine aminotransferase | AVI biosynthesis | 2 | 0 | 0 | 0 | 73 | <0.00001 | |
| Sf1H01920-5-1 | beta glucosidase; iso-1 | AVI carbohydrate metabolism | 1 | 1 | 0 | 0 | 123 | <0.00001 | |
| Sf1H01659-5-1 | putative carboxylesterase | AVI catalytic | 5 | 1 | 0 | 0 | 87 | <0.00001 | |
| Sf9L07277 | enolase | AVI glycolysis | 4 | 1 | 1 | 2 | NS | <0.00001 | |
| Sf9L06272 | glyceraldehyde-3-phosphate dehydrogenase | AVI glycolysis | 1 | 3 | 8 | 3 | 20.82 | <0.0001 | |
| Sf9L02512 | fructose 1 6-bisphosphate aldolase | AVI glycolysis | 0 | 0 | 0 | 1 | 64.61 | <0.00001 | |
| Sf9L02319 | Deoxyribose-phosphate aldolase-like | AVI nucleotide metabolism | 0 | 0 | 0 | 2 | 72 | <0.00001 | |
| Sf1H00106-5-1 | Scavenger receptor;iso-1 (X 2 spots) | BI receptor | 7 | 0 | 0 | 0 | [78–159] | <0.00001 | |
| Sf9L03085 | Cyclophilin 5/peptidyl-propyl isomerase 5 | BII PPIase | 5 | 4 | 4 | 3 | 34 | <0.00001 | |
| Sf9L02900 | similar to RAS suppressor protein 1 | BII Ras signal transduction | 0 | 0 | 0 | 2 | 56 | <0.00001 | |
| Sf1H01096-5-1 | hemicentin (X 3 spots) | BIII CAM | 11 | 0 | 0 | 0 | [117–132]* | <0.00001 | |
| Sf9L07414 | collagen alpha 1 (IV) (X 2 spots) | BIII ECM | 0 | 0 | 0 | 1 | [63–207] | <0.00001 | |
| Sf1H01457-5-1 | collagen alpha 2 (IV) | BIII ECM | 1 | 2 | 0 | 0 | 203 | <0.00001 | |
| Sf9L06099 | cobatoxin-like protein; iso-1 | DI AMP | 0 | 0 | 0 | 2 | 43 | <0.00001 | |
| Sf1H01136-5-1 | lysozyme (X 2 spots) | DI AMP | 140 | 86 | 18 | 0 | 114 | <0.00001 | |
| Sf1H00867-5-1 | hemocytin precursor | DI lectin | 3 | 0 | 0 | 0 | 111 | <0.00001 | |
| Sf1H01505-5-1 | immulectin-2 | DI LPS binding | 5 | 0 | 0 | 0 | 99 | <0.00001 | |
| Sf9L00974 | calreticulin | DI multi-function | 5 | 1 | 0 | 1 | 38 | <0.00001 | |
| Sf1H00566-5-1 | PPO activating Enzyme | DI PPAE | 4 | 0 | 0 | 0 | 196 | <0.00001 | |
| Sf1H02709-3-1 | Hypothetical protein A. gambiae (X 5 spots) | EII | 38 | 0 | 0 | 0 | [88–140]* | <0.00001 | |
| Sf1H02044-5-1 | Hypothetical protein Drosophila | EII | 1 | 0 | 0 | 0 | 137 | <0.00001 | |
| Sf9L08287 | Hypothetical protein A. gambiae | EII | 0 | 0 | 0 | 1 | 47 | <0.00001 | |
| Sf9L06591 | Hypothetical protein Drosophila | EII | 0 | 0 | 0 | 1 | 36 | <0.00001 | |
| Sf9L06826 | Hypothetical protein Drosophila | EII | 0 | 0 | 0 | 1 | 26 | <0.0001 | |
| Sf9L00177 | similar to calponin; iso-1 | EII | 4 | 0 | 0 | 7 | 31 | <0.0001 | |
| Sf1H00681-5-1 | similar to LPS-induced TNF-alpha factor (X 2 spots) | EII | 15 | 2 | 0 | 1 | [123–159] | <0.00001 | |
| Sf1H03038-5-1 | similar to pancreatic triacylglyceride lipase (X 2 spots) | EII | 6 | 0 | 0 | 0 | [81–150] | <0.00001 | |
| Sf1H00115-5-1 | similar to protease inhibitor (AC protein); iso-1 | EII | 3 | 0 | 0 | 0 | 131 | <0.00001 | |
| Sf9L04444 | similar to Swiprosin | EII | 3 | 0 | 0 | 1 | 25 | <0.0001 | |
| Sf1H00035-3-1 | No Similarity | EIII | 19 | 0 | 0 | 0 | 88 | <0.00001 | |
| Sf1H00499-5-1 | No Similarity | EIII | 11 | 0 | 0 | 0 | 14 | <0.001 | |
| Sf1H00686-5-1 | No Similarity | EIII | 10 | 0 | 0 | 0 | 105 | <0.00001 | |
| Sf1H03014-5-1 | No Similarity | EIII | 1 | 2 | 0 | 0 | 178 | <0.00001 | |
| Sf1F00357-5-1 | No Similarity | EIII | 1 | 0 | 0 | 0 | 21 | <0.0001 | |
| Sf1H00037-3-1 | No Similarity | EIII | 1 | 0 | 0 | 0 | 212 | <0.00001 | |
| Sf1H00879-5-1 | No Similarity | EIII | 1 | 0 | 0 | 0 | 147 | <0.00001 | |
| Sf1H01542-3-1 | No Similarity | EIII | 1 | 0 | 0 | 0 | 348 | <0.00001 | |
| Sf1H01712-5-1 | No Similarity | EIII | 1 | 0 | 0 | 0 | 106 | <0.00001 | |
| Sf1H02105-5-1 | No Similarity | EIII | 1 | 0 | 0 | 0 | 163 | <0.00001 | |
| Sf9L00090 | No Similarity | EIII | 1 | 0 | 0 | 4 | 35 | <0.00001 | |
| Sf9L01158 | No Similarity | EIII | 0 | 0 | 1 | 2 | 73 | <0.00001 | |
| Sf9L06863 | No Similarity | EIII | 0 | 0 | 0 | 1 | 43 | <0.00001 | |
| Sf9L08779 | No Similarity | EIII | 0 | 0 | 0 | 1 | NS | <0.00001 | |
| Sf9L07198 | cytoplasmic actin A3 | AIV actin | 27 | 6 | 47 | 2 | 27 | 0.00001 | |
| Sf9L06055 | alpha tubulin | AIV tubulin | 5 | 5 | 7 | 7 | 135 | <0.00001 | |
| Sf9L01568 | beta-1 tubulin | AIV tubulin | 1 | 2 | 2 | 1 | 80 | <0.00001 | |
| Sf9L07277 | enolase | AVI glycolysis | 4 | 1 | 1 | 2 | 39 | <0.00001 | |
| Sf9L02319 | Deoxyribose-phosphate aldolase-like | AVI nucleotide metabolism | 0 | 0 | 0 | 2 | 82 | <0.00001 | |
| Sf9L00974 | calreticulin | DI multi-function | 5 | 1 | 0 | 1 | 85 | <0.00001 | |
| Sf1F00299-5-1 | Hemolymph glycoprotein precursor | DIII unknown | 1 | 17 | 1 | 0 | 33 | <0.00001 | |
| Sf9L00253 | mRNA export factor binding | AII transcription coactivator | 0 | 0 | 0 | 2 | 35 | <0.000001 | |
| Sf9L07586 | Ribosomal protein S27A | AV ribosomal | 5 | 3 | 8 | 11 | 136 | <0.000001 | |
| Sf1H03263-5-1 | MBF2 | C regulator | 10 | 3 | 0 | 0 | 22 | 0.00006 | |
| Sf9L06099 | cobatoxin-like protein; iso-1 | DI AMP | 0 | 0 | 0 | 2 | 70 | <0.000001 | |
| Sf1H00171-5-1 | lysozyme (X 2 spots) | DI AMP | 140 | 86 | 18 | 0 | [10–20] | 0.0001 | |
| Sf9L06812 | immunolectin-A precursor | DI LPS binding | 0 | 1 | 0 | 2 | 137 | <0.000001 | |
| Sf9L02793 | No Similarity | EIII | 0 | 0 | 0 | 1 | 212 | <0.000001 | |
| Sf9L03186 | No Similarity | EIII | 2 | 1 | 7 | 21 | 149 | <0.000001 | |
List of Spodoptera frugiperda genes for which transcript levels are significantly modified in the hemocytes and in the fat body 24 hours after injection of HdIV, and in the fat body 24 hours after injection of JcDNV, as detected by a modified t-test from the SAM package and an ANOVA based microarray analysis, GeneANOVA. Only the genes with a fold change superior or equal to 1.5 with both a FDR median and 90th percentiles of 0% were kept. For each assay, the SAM q-value (the lowest FDR at which the gene is called significant) is given. For each gene, the F value for "gene-condition" and the p-value calculated by GeneANOVA are given. Single genes for which more than one cDNA was spotted on the glass slide are indicated (x spots), in those cases, only the spot with the best score was kept in the list. Genes are organized according to their functional annotation (see Additional file 2 for legends). Spodobase ID: identity of the arrayed cDNA in the database Spodobase ([61]); Gene Name: annotation of the sequence after BlastX search against the GenBank nr database; Functional class: classes and subclasses to which the sequences belong to, based on the classification described in Shida et al. [114] for the ascidian Ciona intestinalis (details in Additional file 2); Number of clones: distribution of the cDNA clones corresponding to the given gene with available sequences in the different S. frugiperda cDNA libraries (H:hemocytes; F: fat body; M:midgut; L:Sf9 cell line). For genes represented by at least two cDNAs, we reported the interval [min, max] for the SAM fold change and for the F gene-condition from GeneANOVA analysis. Asterisk (*) indicate that one of the spots was non significant for GeneANOVA (clusters Sf1H01096-5-1 and Sf1H02709-3-1). The list of additional clones corresponding to each gene is provided in Additional file 1B.
Variation in gene transcript levels in response to virus infection measured by quantitative RT-PCR.
| mean N0 | mean N0 | ||||||||||||||||||||
| HdIV | DNV | control PBS (n = 24) | HdIV (n = 18) | HdIV95° (n = 18) | HdIV | HdIV95 | control Sf (n = 24) | DNV (n = 18) | DNV | ||||||||||||
| fold | fold | fold | min | max | min | max | min | max | fold | fold | min | max | min | max | fold | ||||||
| NS | ND | 0,73 | 1,1 | 11.7 | 48.5 | 3.8 | 10.5 | 3.5 | 5.9 | 4.5 | 4.9 | NS | |||||||||
| 10.7 | ND | 5.3 | 7.0 | 8.7 | 78.9 | 7.1 | 8.7 | NS | 20.5 | 28.1 | 23.7 | 30.3 | NS | ||||||||
| NS | ND | 0.7 | 1.1 | 3.8 | 14.1 | 0.3 | 0.7 | 0.6 | 0.9 | 4.0 | 5.6 | ||||||||||
| 26,0 | ND | 10,6 | 13,0 | 1,8 | 7,0 | 8,4 | 10,6 | NS | 22.0 | 27.9 | 21.5 | 26.9 | NS | ||||||||
| 26.7 | ND | 7,0 | 11,2 | 1,7 | 7,0 | 6.5 | 7.8 | NS | 7.3 | 8.5 | 9.2 | 11.8 | NS | ||||||||
| 66,0 | ND | 22.1 | 31.8 | 2.7 | 9.3 | 20.9 | 29.0 | NS | 20.0 | 31.7 | 3.2 | 12.0 | |||||||||
| 4,0 | ND | 36.0 | 57.6 | 8.2 | 29.1 | 55.4 | 104.3 | 22.7 | 40.8 | 32.4 | 57.0 | NS | |||||||||
| NS | ND | 5,5 | 9,2 | 1,1 | 3,8 | 3.5 | 7.5 | NS | 3.5 | 5.1 | 3.7 | 5.4 | NS | ||||||||
| -- | NS | 9.9 | 13.8 | 10.9 | 12.5 | 39.6 | 133.8 | NS | 33.8 | 37.6 | 45.5 | 67.1 | |||||||||
| -- | NS | 6.5 | 8.9 | 2.0 | 2.9 | 6.5 | 8.6 | NS | 4.5 | 7.2 | 4.8 | 6.8 | NS | ||||||||
Variations in gene transcript levels measured by quantitative RT-PCR in response to virus infection. Calculated mean of the relative cDNA starting quantity (N0) and consequential fold changes (V/C: virus/control) for selected Spodoptera frugiperda genes in control and virus-infected hemocytes and fat body 24 hours after injection. Minimum and maximum values obtained from the 18 or 24 replicates are given in addition to the mean N0 value. For HdIV assays, the control consisted in injection of PBS, for JcDNV (DNV), in injection of healthy S. frugiperda larvae crushed in PBS; HdIV95 corresponds to injections of heat-inactivated HdIV. H/F: ratio of the relative cDNA starting quantity (N0) between hemocytes and fat body in control PBS samples. ND: not done; NS: not significant; fold change threshold at 1.5 for both microarray and quantitative RT-PCR analyses, with FDR median and 90th percentiles at 0%.
Variation in SR-C gene transcript levels measured by quantitative RT-PCR.
| min | mean | max | min | mean | max | min | mean | max | min | mean | max | ||
| 36.1 | 73.1 | 195.3 | 245.7 | 7.8 | 15.3 | 20.9 | 28.2 | ||||||
Variation in SR-C gene transcript levels measured by quantitative RT-PCR in response to injection of Sephadex beads in the hemocyte population collected 6 to 7 hours after injection. Calculated mean of the relative cDNA starting quantity (N0) and consequential fold changes (B/C: beads/control). Fold change threshold at 1.5 for quantitative RT-PCR analyses, with FDR median and 90th percentiles at 0%.